DOBUTamine Hameln IV Injection 250 mg/50 ml
DOBUTamine Hameln IV Injection 250 mg/50 ml is a catecholamine medication used to treat heart failure. It is a synthetic form of dopamine and a sympathomimetic drug, meaning that it mimics the body's own adrenaline, stimulating the heart and increasing blood flow. It is administered intravenously in an emergency or critical care setting as an inotropic agent, meaning it increases the force of the heart's contractions.
Uses
DOBUTamine Hameln IV Injection 250 mg/50 ml is used primarily as a drug for the treatment of severe heart failure. It increases the strength and force of the heart muscle's contractions, helps heart cells use oxygen more efficiently, and increases the amount of blood that the heart pumps per heartbeat. It is used when other treatments, such as diuretics or ACE inhibitors, are no longer effective.
| Brand Name | DOBUTamine Hameln |
|---|---|
| Type | IV Injection |
| Weight | 250 mg/50 ml |
| Generic | Dobutamine |
| Manufacturer | ZAS Corporation |
| Available in | English বাংলা |
Mechanism of Action
DOBUTamine Hameln IV Injection 250 mg/50 ml acts on beta-adrenergic receptors to increase cardiac output by increasing the strength, rate and atrial contraction of the heart muscle. DOBUTamine Hameln IV Injection 250 mg/50 ml binds to beta-receptors, causing them to activate adenylyl cyclase, which in turn increases the amount of cyclic adenosine monophosphate (cAMP) inside the cell. This results in increased calcium and sodium transporters, causing the heart muscle to contract more forcefully.
How Long Does it Take to Work?
DOBUTamine Hameln IV Injection 250 mg/50 ml takes effect within minutes of administration due to its extremely fast absorption rate and rapid effect. The peak effect typically occurs after about 10 minutes, and the effect can last up to an hour.
Absorption
DOBUTamine Hameln IV Injection 250 mg/50 ml is rapidly absorbed into the bloodstream when administered intravenously, with peak concentrations in the blood occurring within minutes.
Route of Elimination
DOBUTamine Hameln IV Injection 250 mg/50 ml is eliminated primarily through the kidneys, with a small percentage removed by the liver. It is eliminated from the body in the form of metabolites.
Dosage
DOBUTamine Hameln IV Injection 250 mg/50 ml is typically administered intravenously or intramuscularly as a continuous infusion. The dose of dobutamine will vary depending on the patient's age, weight, condition, and response to treatment. It may be given in doses ranging from 0.5 to 20 mcg/kg/min. A typical adult dose may range from 2.5 to 20 mcg/kg/min.
Administration
DOBUTamine Hameln IV Injection 250 mg/50 ml can be administered intravenously or intramuscularly. The drug can be titrated using different concentrations of the solution, or it can be given continuously over a longer period of time. The drug is available in several formulations, including tablets, capsules, and a concentrated injectable solution.
Side Effects
The most common side effects of dobutamine include nausea, headache, dizziness, chest pain, palpitations, shortness of breath, and increased heart rate. Other serious side effects can include hypotension, hypertension, arrhythmias, and heart failure.
Toxicity
DOBUTamine Hameln IV Injection 250 mg/50 ml is not known to be toxic. However, if given too quickly, large doses, or for too long, it can cause serious complications such as arrhythmias, hypertension, and heart failure.
Precautions
DOBUTamine Hameln IV Injection 250 mg/50 ml should not be used in patients who are pregnant or breastfeeding, or in patients who have severe bradycardia (slow heart rate). It should also not be used in patients with certain types of arrhythmias, severe hypertension, cardiomyopathy, or peripheral vascular disease. It should be used cautiously in patients with kidney or liver disease.
Interactions
DOBUTamine Hameln IV Injection 250 mg/50 ml can interact with certain medications, such as beta blockers, calcium channel blockers, and ACE inhibitors. It may also interact with other catecholamines, such as epinephrine and norepinephrine, and certain herbal products, such as gingko biloba.
Disease Interaction
DOBUTamine Hameln IV Injection 250 mg/50 ml can interact with certain diseases, such as hypertension, arrhythmias, and heart failure. It should be used cautiously in patients with kidney or liver disease.
Drug Interactions
DOBUTamine Hameln IV Injection 250 mg/50 ml has the potential to interact with certain medications, such as beta blockers, calcium channel blockers, ACE inhibitors, other catecholamines, and certain herbal products. It is important to check with a healthcare professional before taking any medications while on dobutamine.
Food Interactions
DOBUTamine Hameln IV Injection 250 mg/50 ml has no known food interactions. However, it is best to check with your healthcare professional before taking any medications while on dobutamine.
Pregnancy Use
DOBUTamine Hameln IV Injection 250 mg/50 ml should not be used during pregnancy unless it is clearly needed. It can cause fetal harm, and should only be used under the supervision of a healthcare provider.
Lactation Use
DOBUTamine Hameln IV Injection 250 mg/50 ml is not known to be safe to use during lactation. It is best to discuss with your healthcare provider before taking this medication if you are breastfeeding.
Acute Overdose
An acute overdose of dobutamine can cause serious side effects such as arrhythmias, hypertension, and heart failure. If an overdose is suspected, contact a healthcare provider or Poison Control Center immediately.
Contraindication
DOBUTamine Hameln IV Injection 250 mg/50 ml should not be used in patients who are pregnant, breastfeeding, or have known hypersensitivity to the drug. It should also not be used in patients with bradycardia, certain types of arrhythmias, severe hypertension, and cardiomyopathy.
Use Direction
DOBUTamine Hameln IV Injection 250 mg/50 ml should be used exactly as prescribed by your healthcare provider. Follow all instructions for proper administration, dosage, and storage. Do not use more or less than what is prescribed or take for longer than directed.
Storage Condition
DOBUTamine Hameln IV Injection 250 mg/50 ml should be stored at room temperature away from direct light and moisture. It should not be stored in the bathroom or kitchen. Do not freeze the medication and keep it away from children and pets.
Volume of Distribution
The volume of distribution for dobutamine is 0.25 L/kg. This indicates that the drug has a low level of distribution throughout the body and is predominantly found in the plasma.
Half Life
The half-life of dobutamine is 2.5-3.5 hours. This means that it is eliminated from the body relatively quickly, as compared to other drugs with longer half-lives.
Clearance
The clearance of dobutamine is 20-24 mL/min/kg. This indicates that the drug is cleared from the body relatively quickly, but it varies depending on the patient's individual metabolism.
See in details version DOBUTamine Hameln IV Injection 250 mg/50 ml also DOBUTamine Hameln IV Injection 250 mg/50 ml in bangla
